Literature DB >> 5866718

Occurrence of physalaemin in extracts of the skin of Physalaemus fuscumaculatus and its pharmacological actions on extravascular smooth muscle.

G Bertaccini, J M Cei, V Erspamer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5866718      PMCID： PMC1510724          DOI： 10.1111/j.1476-5381.1965.tb02056.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  8 in total

1.  The isolation and amino acid sequence of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone.

Authors:  A ANASTASI; V ERSPAMER
Journal:  Arch Biochem Biophys       Date:  1963-04       Impact factor: 4.013

2.  ISOLATION AND AMINO ACID SEQUENCE OF PHYSALAEMIN, THE MAIN ACTIVE POLYPEPTIDE OF THE SKIN OF PHYSALAEMUS FUSCUMACULATUS.

Authors:  A ANASTASI; V ERSPAMER; J M CEI
Journal:  Arch Biochem Biophys       Date:  1964-11       Impact factor: 4.013

3.  OCCURENCE OF BRADYKININ IN THE SKIN OF RANA TEMPORARIA.

Authors:  A ANASTASI; V ERSPAMER; G BERTACCINI
Journal:  Comp Biochem Physiol       Date:  1965-01

4.  Nucleolar localization of succinic dehydrogenase in human malignant cells with MTT.

Authors:  P DE; R CHATTERJEE
Journal:  Experientia       Date:  1962-12-15

5.  The stability of purified preparations of substance P.

Authors:  J CLEUGH; J H GADDUM
Journal:  Experientia       Date:  1963-02-15

6.  Substance P, a highly active naturally occurring polypeptide.

Authors:  W HAEFELY; A HUERLIMANN
Journal:  Experientia       Date:  1962-07-15

7.  Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus.

Authors:  V Erspaemer; A Anastasi; G Bertaccini; J M Cei
Journal:  Experientia       Date:  1964-09-15

8.  Synthesis of physalaemin.

Authors:  L Bernardi; G Bosisio; O Goffredo; R De Castiglione
Journal:  Experientia       Date:  1964-09-15
  8 in total
  16 in total

1.  The action of gantrisin [N'-(3,4-dimethyl-5-isoxazolyl)sulfanilamide] on the oedema-forming and muscle-stimulating activity of eledoisin and physalaemin.

Authors:  G de Caro; G Improta; L Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  High-sensitivity radioimmunoassay for substance P.

Authors:  R O'Connell; P Skrabanek; D Cannon; D Powell
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

3.  Proceedings: Effects on salivary glands of the chronic administration of eledoisin and physalaemin to rats.

Authors:  F Cantalamessa; G De Caro; M Perfumi
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

4.  Action of eledoisin on human lacrimal secretion in normal and pathological conditions.

Authors:  M Impicciatore; G Maraini; G Bertaccini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  The use of preparations of urinary bladder smooth muscle for bioassay of and discrimination between polypeptides.

Authors:  G F Erspamer; L Negri; D Piccinelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  Comparison of crude bovine subcortical substance P with synthetic substance P.

Authors:  H Iven; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Active polypeptides in amphibian skin.

Authors:  G Bertaccini
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

8.  The action of physalaemin on the systemic arterial blood pressure of some experimental animals.

Authors:  G Bertaccini; J M Cei; V Erspamer
Journal:  Br J Pharmacol Chemother       Date:  1965-10

9.  Differentiation of substance P and physalaemin.

Authors:  F Geipert; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

10.  Pharmacological data on phyllokinin (bradykinyl-isoleucyl-tyrosine o-sulphate) and bradykinyl-isoleucyl-tyrosine.

Authors:  A Anastasi; G Bertaccini; V Erspamer
Journal:  Br J Pharmacol Chemother       Date:  1966-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.